Clinical Study of Allogeneic V γ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma
Conditions: GBM; DIPG Brain Tumor; Medulloblastoma Interventions: Biological: V γ9Vδ2 T cell Sponsors: Beijing Tiantan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Glioma | Hospitals | Medulloblastoma | Neurology | Research | Study